- Home
- BOLT vs GFAI Comparison
BOLT vs GFAI Comparison
Compare BOLT & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- GFAI
- Stock Information
- Founded
- BOLT 2015
- GFAI 2018
- Country
- BOLT United States
- GFAI Singapore
- Employees
- BOLT 100
- GFAI N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- GFAI Diversified Commercial Services
- Sector
- BOLT Health Care
- GFAI Consumer Discretionary
- Exchange
- BOLT Nasdaq
- GFAI Nasdaq
- Market Cap
- BOLT 25.3M
- GFAI N/A
- IPO Year
- BOLT 2021
- GFAI N/A
- Fundamental
- Price
- BOLT $0.64
- GFAI $1.22
- Analyst Decision
- BOLT Hold
- GFAI Strong Buy
- Analyst Count
- BOLT 5
- GFAI 2
- Target Price
- BOLT $1.25
- GFAI $6.75
- AVG Volume (30 Days)
- BOLT 143.6K
- GFAI 281.0K
- Earning Date
- BOLT 11-07-2024
- GFAI 10-25-2024
- Dividend Yield
- BOLT N/A
- GFAI N/A
- EPS Growth
- BOLT N/A
- GFAI N/A
- EPS
- BOLT N/A
- GFAI N/A
- Revenue
- BOLT $11,166,000.00
- GFAI $35,841,743.00
- Revenue This Year
- BOLT $16.30
- GFAI N/A
- Revenue Next Year
- BOLT N/A
- GFAI N/A
- P/E Ratio
- BOLT N/A
- GFAI N/A
- Revenue Growth
- BOLT 64.64
- GFAI 1.78
- 52 Week Low
- BOLT $0.55
- GFAI $1.03
- 52 Week High
- BOLT $1.56
- GFAI $4.30
- Technical
- Relative Strength Index (RSI)
- BOLT 48.78
- GFAI 51.74
- Support Level
- BOLT $0.62
- GFAI $1.13
- Resistance Level
- BOLT $0.68
- GFAI $1.22
- Average True Range (ATR)
- BOLT 0.03
- GFAI 0.07
- MACD
- BOLT 0.00
- GFAI 0.02
- Stochastic Oscillator
- BOLT 47.37
- GFAI 64.71
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.